Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 4

Zeitschriftenartikel

Müller, Rüdiger B.; Hasler, Caroline; Popp, Florian; Mattow, Frederik; Durmisi, Mirsada; Souza, Alexander; Hasler, Paul; Rubbert-Roth, Andrea; Schulze-Koops, Hendrik und Kempis, Johannes von (2019): Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts. In: Journal of Clinical Medicine, Bd. 8, Nr. 10, 1548

Müller, Rüdiger B.; Späth, Michael; Restorff, Cord von; Ackermann, Christoph; Schulze-Koops, Hendrik und Kempis, Johannes von (2019): Superiority of a Treat-to-Target Strategy over Conventional Treatment with Fixed csDMARD and Corticosteroids: A Multi-Center Randomized Controlled Trial in RA Patients with an Inadequate Response to Conventional Synthetic DMARDs, and New Therapy with Certolizumab Pegol. In: Journal of Clinical Medicine, Bd. 8, Nr. 3, 302

Kempis, Johannes von; Duetsch, Sabine; Reuschling, Nicola; Villiger, Rahel; Villiger, Peter M.; Vallelian, Florencee; Schär, Dominik J. und Müller, Rüdiger B. (2019): Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland. In: Swiss Medical Weekly, Bd. 149, w20022

Müller, Rüdiger B.; Reshiti, Nazim; Kägi, Toni; Finckh, Axel; Haile, Sarah R.; Schulze-Koops, Hendrik; Schiff, Michael; Späth, Michael und Kempis, Johannes von (2017): Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM). In: Clinical Rheumatology, Bd. 36, Nr. 1: S. 59-66

Diese Liste wurde am Sat Mar 23 23:15:44 2024 CET erstellt.